Archer Materials Cracks Quantum Readout Challenge as Stock Surges 12%

Archer Materials Just Solved One of Quantum Computing’s Hardest Problems

Archer Materials (ASX: AXE) jumped 12% today after unveiling two key developments: successful quantum readout of single electrons and a new quantum machine learning collaboration with CSIRO. The company has now achieved a major milestone in its 12CQ quantum chip roadmap, marking tangible progress toward commercial feasibility. As CEO Simon Ruffell put it, “Achieving readout and control is key for our qubit demonstration, and the qubit is the foundation for building a full quantum chip.”

What are the Best Tech ASX Stocks to invest in right now?

Check our buy/sell tips

Archer QTUM chip explained

For investors, we will try to break down quantum computing as simply as possible, although it is one of the most complex technologies around. Archer Materials is effectively developing a new type of quantum qubit built from carbon-based materials rather than traditional silicon. In simple terms, a qubit acts as the brain of the quantum chip, it stores information as either 0, 1, or both at once. To use this information, the system must be able to read that state precisely, which has long been one of the biggest technical hurdles in quantum computing. Up until now, Archer had been able to detect quantum signals, but not measure them accurately enough to confirm control.

The company has now shown that it can do exactly that. Archer built ultra-small switches on its chip, called single-electron transistors, positioned right next to its carbon qubits. For the first time, it proved that these can be turned on and off using simple electrical signals. This achievement matters because a reliable readout is the hardest part of building a working quantum chip. Archer has demonstrated that it can perform this process using its proprietary carbon material, a key step that meaningfully reduces technical risk and strengthens its roadmap toward a commercially viable quantum processor.

The problem QTUM computers face when reading Qubits

Most quantum computers today need enormous, ultra-cold machines to read qubits, but Archer’s device can do it using simple electrical signals. This dramatically reduces the technical complexity and risk of the system. On top of that, Archer’s use of carbon-based films is strategically important because they are compatible with standard CMOS semiconductor manufacturing. In other words, Archer’s quantum chips could potentially be built using the same fabrication processes that power the world’s existing electronics, a capability that positions the company uniquely within the broader quantum race.

CSIRO partnership in fraud detection

The second part of the announcement focused on a 12-month partnership with CSIRO to co-develop quantum machine learning models for fraud detection in financial transactions. This collaboration signals that Archer Materials is expanding beyond pure hardware development and beginning to build an application-layer software presence within the quantum ecosystem. By targeting fraud detection, a multibillion-dollar global problem, Archer is positioning itself at the intersection of quantum computing and financial technology, two of the fastest-growing innovation frontiers.

The investors Takeaway for AXE

While the news is undeniably positive, investors should remain mindful that Archer Materials is still a pre-revenue company. It has a solid balance sheet with roughly A$13M in cash, providing an estimated three years of funding at its current burn rate. However, further dilution is likely as the company continues to fund R&D and move toward commercial milestones.

It’s also important to recognise that Archer is still several years away from generating revenue. The 12CQ project has been in development for around eight years, and the full qubit demonstration is not expected until 2026. If progress stalls or the next major milestone fails to deliver, investor sentiment could reverse sharply. History shows that many early-stage quantum companies have struggled to translate scientific breakthroughs into sustainable commercial traction. For now, the market is rewarding momentum, but execution risk remains high.